NanoSynex

📍 Tel Aviv, Israel🗓 Founded 2017👥 18 employees💰 Last funded Feb 2018
Biotechnology Research🌐 nanosynex.com
Website LinkedIn
NanoSynex is developing a diagnostic test that can check bacterial resistance to antibiotics in a record time using microfluidics techniques, based on a revolutionary scientific development from the Technion. The test will help doctors determine the most appropriate antibiotic treatment for their patients and provide same day results, which will reduce the spread of resistant bacteria in the environment and significantly lower the burden on healthcare costs.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
1
Frequently asked questions
Who invested in NanoSynex?
NanoSynex has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NanoSynex last raise funding?
The most recent investment in NanoSynex recorded on gritt.io was in February 2018.
When was NanoSynex founded?
NanoSynex was founded in 2017.
What industry is NanoSynex in?
NanoSynex operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NanoSynex based?
NanoSynex is headquartered in Tel Aviv, Israel.